Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-235-2 | CAS number: 517-23-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral Toxicity:
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- not available
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- other: usual manner
- Principles of method if other than guideline:
- The test substance is administered orally by gavage in graduated doses to several groups of experimental animals for 5 days, one dose being used per group. Subsequently observations of effects and deaths are made after 24 hours, 2 days, 3 days, 4 days, 5 days followed by an post observation period of 10 days (= 15 days after the first dosage).
- GLP compliance:
- no
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- not specified
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- no further information available
- Doses:
- 1000, 2000, 4000 and 8000 mg/kg bw
- No. of animals per sex per dose:
- 10 animals per dosage group
- Control animals:
- no
- Details on study design:
- no further information available
- Sex:
- not specified
- Dose descriptor:
- LD50
- Remarks:
- observation period: 24 hours
- Effect level:
- 5 640 mg/kg bw
- Sex:
- not specified
- Dose descriptor:
- other: LD90
- Remarks:
- observation period: 24 hours
- Effect level:
- 7 080 mg/kg bw
- Sex:
- not specified
- Dose descriptor:
- other: LD10
- Remarks:
- observation period: 24 hours
- Effect level:
- 4 500 mg/kg bw
- Sex:
- not specified
- Dose descriptor:
- discriminating dose
- Remarks:
- treatment over 5 days and 10 days post observation period
- Effect level:
- 3 000 mg/kg bw
- Mortality:
- 24 hours after the first administration:
8000 mg/kg bw: 10/10 dead
4000 mg/kg bw: 0/10
2000 mg/kg bw: 0/10
1000 mg/kg bw: 0/10 - Clinical signs:
- other: sedation, hypoventilation
- Gross pathology:
- not examined
- Executive summary:
The tests were carried out in the usual manner (oral, gavage), 10 animals per dosage group. The lethal doses were determined by the computer method developed by Dr S. Wolf. The LD 10, LD 50, and LD 90 are calculated on the basis of the mortality data reported 24 hours after administration of a single dose. the LD 50 value for the test substance was reported to be > 2000 mg/kg bw.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- not available
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- other: usual manner
- Principles of method if other than guideline:
- no further information available
- GLP compliance:
- no
- Test type:
- standard acute method
- Species:
- mouse
- Strain:
- not specified
- Sex:
- not specified
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- no further information available
- Doses:
- 1000, 2000, 4000, 8000 mg/kg bw
- No. of animals per sex per dose:
- 10 animals per dosage group
- Control animals:
- no
- Details on study design:
- no further information available
- Sex:
- not specified
- Dose descriptor:
- LD50
- Remarks:
- observation period: 24 h and 10 days
- Effect level:
- 8 500 mg/kg bw
- Sex:
- not specified
- Dose descriptor:
- other: LD90
- Remarks:
- observation period: 24 h and 10 days
- Effect level:
- 10 600 mg/kg bw
- Sex:
- not specified
- Dose descriptor:
- other: LD10
- Remarks:
- observation period: 24 h and 10 days
- Effect level:
- 6 700 mg/kg bw
- Mortality:
- 4000 ersterTag 5/10
- Clinical signs:
- other: sedation, hypoventilation
- Gross pathology:
- no information available
- Executive summary:
The tests were carried out in the usual manner (oral, gavage), using 10 mice per dosage group. The lethal doses were determined by the computer method developed by Dr S. Wolf. The LD 10, LD 50, and LD 90 are stated for observation period of 24 h and 10 days. The LD 50 value for the test substance was reported to be 8500 (+- 670) mg/kg bw.
Referenceopen allclose all
Although the LD50 value was calculated from a study with repeated administration (5 days), taken the mortality data 24 hours after the first administration, this value allows for a reliable assessment of the acute oral toxicity. The LD50 value is still above 2000 mg/kg bw even if the dosage was extented over five days (post observation period: 10 days).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Although both studies do not meet the recent requirements they provide a convincing picture of the acute oral toxicity of the substance.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Based on the study results for acute oral toxicity no classification according to Regulation (EC) No. 1272/2008 (CLP), ANNEX I, is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.